Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuantong Li

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Clinical Medicine Insights. Oncology|July 19, 2021
A novel germline BRCA1 mutation identified in a family with hereditary breast and ovarian cancer syndromeYanmei Wu, Xiaodong Pan, Juan Dou, et al.
Bioinformatics (Oxford, England)|May 27, 2021
Peel learning for pathway-related outcome predictionYuantong Li, Fei Wang, Mengying Yan, et al.
International Immunopharmacology|December 14, 2025
Targeting Cbl-b by a small molecular inhibitor potentiates T cell receptor signaling and suggests rational combination strategiesYuantong Li, Haotian Tang, Wenhao Shi, et al.
Molecules (Basel, Switzerland)|April 27, 2024
A Novel IRAK4 Inhibitor DW18134 Ameliorates Peritonitis and Inflammatory Bowel DiseaseYuqing Huang, Yi Ning, Zhiwei Chen, et al.
Cancer Cell International|July 27, 2025
Dual targeting of VEGFR2 and CSF1R with SYHA1813 confers novel strategy for treating both BRAF wild-type and mutant melanomaWenhao Shi, Haotian Tang, Linjiang Tong, et al.
International Journal of Biological Sciences|November 6, 2023
A novel lncRNA-mediated epigenetic regulatory mechanism in periodontitisZoe Xiaofang Zhu, Yao Liu, Jinghao Wang, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Clinical Medicine Insights. Oncology|July 19, 2021
A novel germline BRCA1 mutation identified in a family with hereditary breast and ovarian cancer syndromeYanmei Wu, Xiaodong Pan, Juan Dou, et al.
Bioinformatics (Oxford, England)|May 27, 2021
Peel learning for pathway-related outcome predictionYuantong Li, Fei Wang, Mengying Yan, et al.
International Immunopharmacology|December 14, 2025
Targeting Cbl-b by a small molecular inhibitor potentiates T cell receptor signaling and suggests rational combination strategiesYuantong Li, Haotian Tang, Wenhao Shi, et al.
Molecules (Basel, Switzerland)|April 27, 2024
A Novel IRAK4 Inhibitor DW18134 Ameliorates Peritonitis and Inflammatory Bowel DiseaseYuqing Huang, Yi Ning, Zhiwei Chen, et al.
Cancer Cell International|July 27, 2025
Dual targeting of VEGFR2 and CSF1R with SYHA1813 confers novel strategy for treating both BRAF wild-type and mutant melanomaWenhao Shi, Haotian Tang, Linjiang Tong, et al.
International Journal of Biological Sciences|November 6, 2023
A novel lncRNA-mediated epigenetic regulatory mechanism in periodontitisZoe Xiaofang Zhu, Yao Liu, Jinghao Wang, et al.
Pageof 1